Karyopharm Therapeutics (25K0.MU) Q3 2026 Earnings

30JulConfirmed
Q1 2026
Next
Next
-4.81
-3.56
-2.31
-1.06

Details

Expected EPS
-1.06145061516
Actual EPS
N/A
Surprise EPS
1.06
Surprise Percent
+100%

Description

Karyopharm Therapeutics (25K0.MU) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts